Arthritis Gouty

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2026-08-19
EMA Authorised: Febuxostat Viatris (previously Febuxostat Mylan) (febuxostat) — Viatris Limited
European Medicines Agency authorised Febuxostat Viatris for hyperuricemia and gout-related indications.